FDA Inspection 1162194 — Nationwide Childrens Hospital Transfusion Service
The FDA completed an inspection of Nationwide Childrens Hospital Transfusion Service on Feb 8, 2022 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 8, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Columbus, OH (United States)